MaxCyte (MXCT) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MaxCyte, Inc. has issued 298,824 shares of common stock as part of its incentive plan, with total voting rights now standing at 104,395,574 shares. The company has also provided an update on its block listing return, indicating a remaining balance of 9,038,342 unallotted ordinary shares. MaxCyte focuses on cell engineering technologies aimed at advancing cell-based therapeutics and bioprocessing applications.
For further insights into MXCT stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue